🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Tyrosine kinase inhibitors (TKI) have revolutionized the management and pro...
Status
Active Not Recruiting
Location
Chu Angers
Start Date
2023-12-01
Trial ID
NCT05753384
Treatments Being Tested
This phase II trial studies how well pioglitazone hydrochloride and tyrosin...
Status
Terminated
Location
Emory University/Winship Cancer Institute
Start Date
2016-05
Trial ID
NCT02730195
Treatments Being Tested
The goal of this clinical research study is to learn if adding pegylated in...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2011-10
Trial ID
NCT01392170
Treatments Being Tested
The purpose of this prospective, single-institution observational study is ...
Status
Completed
Location
UNC Hospital
Start Date
2019-06-20
Trial ID
NCT03885830
This study will enroll CML patients who have failed a first TKI stopping at...
Status
Unknown
Location
Aarhus University Hospital
Start Date
2018-02-01
Trial ID
NCT03573596
Treatments Being Tested
Primary objective : To identify epigenetic dysregulations of in vivo TKI-re...
Status
Unknown
Location
CHU Annecy-Genevois
Start Date
2018-02-01
Trial ID
NCT03481868
Treatments Being Tested
Improving the quality of life and achieving Treatment-Free Remission(TFR) i...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-07-31
Trial ID
NCT05440747
Treatments Being Tested
The objective of this Phase II study is to assess the potential of ascimini...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2025-02-18
Trial ID
NCT06514534
Treatments Being Tested
The purposes of this study are to investigate expression and frequency of A...
Status
Unknown
Location
Seoul St. Mary's Hospital
Start Date
2011-07
Trial ID
NCT01562847
Treatments Being Tested
RATIONALE: Tyrosine kinase inhibitors may stop the growth of cancer cells b...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2006-09
Trial ID
NCT00363649
Treatments Being Tested